These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 12502446

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK, Boletis JN, Makris F, Psichogiou M, Kostakis A, Hatzakis A.
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [Abstract] [Full Text] [Related]

  • 3. [Fatal fibrosing cholestatic hepatitis following renal transplantation].
    Sprengers D, van Gelder T, Zondervan PE, Niesters HG, Janssen HL, de Man RA.
    Ned Tijdschr Geneeskd; 2002 Jul 20; 146(29):1380-4. PubMed ID: 12162178
    [Abstract] [Full Text] [Related]

  • 4. Fulminant hepatic failure in a renal transplant recipient with positive hepatitis B surface antigens: a case report of fibrosing cholestatic hepatitis.
    Hung YB, Liang JT, Chu JS, Chen KM, Lee CS.
    Hepatogastroenterology; 1995 Jul 20; 42(6):913-8. PubMed ID: 8847045
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC, Yan LN, Li B, Wen TF, Zhao JC, Cheng NS, Liu C, Liu J, Wang XB, Li XD, Qin S, Zhao LS, Lei BJ, Zhang XH.
    Hepatobiliary Pancreat Dis Int; 2004 Feb 20; 3(1):26-32. PubMed ID: 14969833
    [Abstract] [Full Text] [Related]

  • 8. Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine.
    Al Faraidy K, Yoshida EM, Davis JE, Vartanian RK, Anderson FH, Steinbrecher UP.
    Transplantation; 1997 Sep 27; 64(6):926-8. PubMed ID: 9326423
    [Abstract] [Full Text] [Related]

  • 9. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
    Gwak GY, Huh W, Lee DH, Choi MS, Lee JH, Koh KC, Kim SJ, Joh JW, Oh HY.
    Transplant Proc; 2007 Dec 27; 39(10):3121-6. PubMed ID: 18089336
    [Abstract] [Full Text] [Related]

  • 10. Treatment of fibrosing cholestatic hepatitis with lamivudine.
    Chan TM, Wu PC, Li FK, Lai CL, Cheng IK, Lai KN.
    Gastroenterology; 1998 Jul 27; 115(1):177-81. PubMed ID: 9649474
    [Abstract] [Full Text] [Related]

  • 11. [Fibrosing cholestatic hepatitis by B virus reactivation in AIDS].
    Poulet B, Chapel F, Dény P, Schneider MC, Jeantils V, Beaugrand M, Guettier C.
    Ann Pathol; 1996 Jul 27; 16(3):188-91. PubMed ID: 8766176
    [Abstract] [Full Text] [Related]

  • 12. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
    Lo CM, Liu CL, Chan SC, Lau GK, Fan ST.
    J Hepatol; 2005 Aug 27; 43(2):283-7. PubMed ID: 15964658
    [Abstract] [Full Text] [Related]

  • 13. Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients.
    Cotler SJ, Taylor SL, Gretch DR, Bronner MP, Rizk R, Perkins JD, Carithers RL.
    Am J Gastroenterol; 2000 Mar 27; 95(3):753-9. PubMed ID: 10710070
    [Abstract] [Full Text] [Related]

  • 14. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience.
    Murakami R, Amada N, Sato T, Orii T, Kikuchi H, Haga I, Ohashi Y, Okazaki H.
    Clin Transplant; 2006 Mar 27; 20(3):351-8. PubMed ID: 16824154
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.
    Transplant Proc; 2005 Sep 27; 37(7):3045-7. PubMed ID: 16213299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.